Clinical Trials

NCT02346721 | COMPLETED | PHASE3

111 participants

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2015-02-23

Completion:

2016-03-23

Conditions

• Hepatitis C Virus Infection

Interventions

• DRUG

Results Available

NCT02343133 | COMPLETED | PHASE2

200 participants

Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2015-01-31

Completion:

2016-04-30

Conditions

• Hematopoietic Syndrome Due to Acute Radiation Syndrome

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT02337660 | COMPLETED | NA

30 participants

Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2015-01-31

Completion:

2016-01-31

Conditions

• Non-alcoholic Fatty Liver Disease

Interventions

• PROCEDURE
• OTHER

No Results Yet

NCT02334527 | TERMINATED | PHASE2

12 participants

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2015-03-17

Completion:

2016-12-02

Conditions

• Metastatic Urothelial Carcinoma (UC)

Interventions

• DRUG

Results Available

NCT02300103 | COMPLETED | PHASE2

69 participants

Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2014-12-01

Completion:

2016-07-02

Conditions

• Hepatitis C Virus Infection

Interventions

• DRUG

Results Available

NCT02259036 | COMPLETED | NA

40 participants

Using Smartphones to Enhance the Treatment of Childhood Anxiety

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2014-08-31

Completion:

2017-05-31

Conditions

• Anxiety

Interventions

• OTHER

No Results Yet

NCT02241369 | COMPLETED | PHASE1

3 participants

Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2014-05-31

Completion:

2018-09-30

Conditions

• Aerodigestive Precancerous Lesions and Malignancies

Interventions

• BIOLOGICAL

No Results Yet

NCT02238951 | COMPLETED | NA

60 participants

Cancer Care Coordination for Chemotherapy Patients

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-12-31

Completion:

2017-10-31

Conditions

• Cancer

Interventions

• OTHER

No Results Yet

NCT02226549 | COMPLETED | PHASE2

47 participants

Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2014-07-31

Completion:

2015-02-28

Conditions

• Hepatitis C Virus Infection

Interventions

• DRUG

Results Available

NCT02219685 | COMPLETED | PHASE2

40 participants

Ledipasvir/Sofosbuvir Fixed-Dose Combination on Cerebral Metabolism and Neurocognition in Treatment-Naive and Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2014-08-31

Completion:

2015-08-31

Conditions

• Hepatitis C Virus Infection

Interventions

• DRUG

Results Available

NCT02202980 | COMPLETED | PHASE2

273 participants

Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2014-08-04

Completion:

2016-03-16

Conditions

• Chronic Hepatitis C

Interventions

• DRUG

Results Available

NCT02201953 | COMPLETED | PHASE3

558 participants

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2014-07-31

Completion:

2015-09-30

Conditions

• Hepatitis C Virus Infection

Interventions

• DRUG

Results Available

NCT02096627 | COMPLETED

154 participants

Comparison of Femtosecond Laser Assisted Cataract Surgery to Conventional Phacoemulsification Cataract Surgery

Study Type:

OBSERVATIONAL

Last Updated:

2018-11-16

Start Date:

2014-05-31

Completion:

2018-11-30

Conditions

• Cataract

No Results Yet

NCT02073656 | COMPLETED | PHASE3

335 participants

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2014-02-28

Completion:

2014-11-30

Conditions

• Hepatitis C Virus
• HIV

Interventions

• DRUG

Results Available

NCT02071082 | COMPLETED | PHASE3

79 participants

Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2014-02-25

Completion:

2015-01-23

Conditions

• HIV
• HBV

Interventions

• DRUG

Results Available

NCT01975675 | COMPLETED | PHASE3

341 participants

Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-10-31

Completion:

2014-06-30

Conditions

• Chronic HCV Infection

Interventions

• DRUG

Results Available

NCT01968551 | COMPLETED | PHASE3

158 participants

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-09-03

Completion:

2015-07-21

Conditions

• HIV-1
• HIV Infections
• Acquired Immunodeficiency Syndrome

Interventions

• DRUG

Results Available

NCT01967940 | COMPLETED | PHASE3

55 participants

Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-10-25

Completion:

2015-05-21

Conditions

• HIV
• HIV Infections
• Acquired Immunodeficiency Syndrome

Interventions

• DRUG

Results Available

NCT01965535 | COMPLETED | PHASE2

155 participants

Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-10-31

Completion:

2014-08-31

Conditions

• HCV Infection

Interventions

• DRUG

Results Available

NCT01938430 | COMPLETED | PHASE2

339 participants

Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-09-30

Completion:

2015-01-31

Conditions

• Chronic HCV Infection

Interventions

• DRUG

Results Available

NCT01936389 | COMPLETED | PHASE2

10 participants

A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-09-30

Completion:

2014-10-31

Conditions

• Exfoliation Syndrome
• Ocular Hypertension
• Open Angle Glaucoma

Interventions

• DRUG

Results Available

NCT01853982 | TERMINATED | PHASE3

4 participants

Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-06-14

Completion:

2013-11-20

Conditions

• Ventilator-Associated Pneumonia (VAP)

Interventions

• DRUG

Results Available

NCT01851330 | COMPLETED | PHASE3

647 participants

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-05-31

Completion:

2013-12-31

Conditions

• Chronic Hepatitis C Virus

Interventions

• DRUG

Results Available

NCT01826981 | COMPLETED | PHASE2

359 participants

Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-04-30

Completion:

2015-03-31

Conditions

• Chronic Hepatitis C

Interventions

• DRUG

Results Available

NCT01768286 | COMPLETED | PHASE3

441 participants

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-01-31

Completion:

2013-11-30

Conditions

• Chronic Hepatitis C Virus

Interventions

• DRUG

Results Available

NCT01757132 | ENROLLING_BY_INVITATION | NA

770 participants

Post-Approval Study of the Implantable Miniature Telescope

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2010-08-31

Completion:

2023-12-31

Conditions

• AMD

Interventions

• DEVICE

No Results Yet

NCT01742221 | COMPLETED | PHASE1

60 participants

Safety and Tolerability of HemaMax™ (rHuIL-12) as Radiation Countermeasure

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2012-08-31

Completion:

2012-11-30

Conditions

• Hematopoietic Syndrome Due to Acute Radiation Syndrome

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT01732926 | TERMINATED | PHASE3

475 participants

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-01-02

Completion:

2016-05-17

Conditions

• Indolent Non-Hodgkin's Lymphomas

Interventions

• DRUG

Results Available

NCT01732913 | TERMINATED | PHASE3

295 participants

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-01-16

Completion:

2016-05-18

Conditions

• Indolent Non-Hodgkin's Lymphomas

Interventions

• DRUG

Results Available

NCT01726517 | COMPLETED | PHASE2

100 participants

Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2012-10-31

Completion:

2013-07-31

Conditions

• Chronic Hepatitis C Virus

Interventions

• DRUG

Results Available

NCT01701401 | COMPLETED | PHASE3

870 participants

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2012-09-30

Completion:

2014-03-31

Conditions

• Chronic Hepatitis C Virus

Interventions

• DRUG

Results Available

NCT01679301 | COMPLETED | NA

11 participants

Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2012-09-30

Completion:

2014-07-31

Conditions

• Lung Disease

Interventions

• DEVICE

Results Available

NCT01672138 | UNKNOWN | NA

186 participants

Pulmonary Vein Antrum Isolation (PVAI) Plus Scar Homogenization and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-02-28

Completion:

2019-12-31

Conditions

• Persistent Atrial Fibrillation
• Long-standing Persistent Atrial Fibrillation

Interventions

• PROCEDURE

No Results Yet

NCT01513655 | UNKNOWN | PHASE4

150 participants

Home Non Invasive Ventilation (NIV) Treatment for COPD-patients After a NIV-treated Exacerbation

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2013-07-31

Completion:

2019-07-31

Conditions

• Chronic Obstructive Pulmonary Disease
• Acute Exacerbation of Chronic Obstructive Airways Disease
• Chronic Hypercapnic Respiratory Failure

Interventions

• DEVICE

No Results Yet

NCT01506024 | COMPLETED | NA

60 participants

Minimal Invasive Surgery in Total Hip Arthroplasty Patients; Short- and Long Term Results

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2011-09-30

Completion:

2014-04-30

Conditions

• Hip Osteoarthritis

Interventions

• PROCEDURE

No Results Yet

NCT01445678 | COMPLETED | PHASE3

494 participants

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2011-12-23

Completion:

2013-10-03

Conditions

• Complicated Intra-abdominal Infection

Interventions

• DRUG

Results Available

NCT01422837 | COMPLETED

403 participants

ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry

Study Type:

OBSERVATIONAL

Last Updated:

2018-11-16

Start Date:

2011-08-31

Completion:

2013-10-31

Conditions

• Opioid Dependence

No Results Yet

NCT01262326 | COMPLETED | NA

60 participants

Determination of the Effect of Extreme Dietary Carbohydrate Restriction on Hepatic Glucose Production

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2005-01-31

Completion:

2011-12-31

Conditions

• Non-Alcoholic Fatty Liver Disease

Interventions

• OTHER

No Results Yet

NCT01247363 | COMPLETED | PHASE1

20 participants

A Study of LY2608204 in Patients With Type 2 Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2010-11-30

Completion:

2011-03-31

Conditions

• Diabetes Mellitus, Type 2

Interventions

• DRUG

Results Available

NCT01203930 | TERMINATED | PHASE2

105 participants

A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL

Study Type:

INTERVENTIONAL

Last Updated:

2018-11-16

Start Date:

2010-10-31

Completion:

2015-08-31

Conditions

• Chronic Lymphocytic Leukemia (CLL)
• Small Lymphocytic Lymphoma (SLL)

Interventions

• DRUG

Results Available